Uncovering moonlighting role of mitochondrial presequence translocase machinery in SOD1-mediated ALS pathogenesis

Familial Amyotrophic Lateral Sclerosis (fALS) is a fatal neurodegenerative disease, mainly caused by mutations in the superoxide dismutase 1 (SOD1) protein. Mitochondrial dysfunction is a primary hallmark of ALS pathogenesis. However, the molecular mechanism by which SOD1 mutants impair organellar health remains enigmatic. This study demonstrates that mutant SOD1 associates with the TIM23 complex in Saccharomyces cerevisiae via its intermembrane space (IMS) domain. In ALS-associated SOD1 mutants, both binding and expression of TIM23 complex proteins were downregulated, leading to altered translocation of the substrate protein Sdh3, a component of the electron transport chain (ETC) complex II. Disrupted Sdh3 translocation leads to mitochondrial dysfunction, evidenced by decreased ETC complex II activity, reduced functional mass, and compromised organelle integrity. Overexpression of Tim23 partially rescued mitochondrial integrity by increasing ETC complex activity and functional mass and restoring reticular morphology. Strikingly, the improved mitochondrial homeostasis in Tim23-overexpressing cells partially rescued the growth defects caused by mutant SOD1. Collectively, these findings reveal a previously unrecognized regulatory axis between mutant SOD1 and the mitochondrial pre-sequence translocase machinery, highlighting this pathway as a promising target for future ALS therapies and opening new avenues for mechanistic and translational research. Author SummaryFamilial Amyotrophic Lateral Sclerosis (fALS) is a progressive, fatal neuromuscular disorder marked by motor neuron degeneration. The exact cause of ALS remains unclear. Previous research links familial ALS to mutations in the superoxide dismutase 1 (SOD1) gene. SOD1 mutants in ALS disrupt mitochondrial protein translocation, a key mitochondrial process. The mechanism by which SOD1 mutants affect mitochondrial function and integrity by modulating presequence translocase (TIM23 complex) import is not yet understood. The current study addresses a critical gap in ALS research by demonstrating a novel, direct interaction between SOD1 and Tim23 that regulates mitochondrial function in yeast. We found that SOD1 binds Tim23 via Tim23 IMS domain, stabilizes the Tim23CORE complex, enabling Sdh3 import. Loss of SOD1, Tim23, or Tim50 destabilizes the TIM23CORE complex, leading to impaired Sdh3 import and decreased ETC complex-II activity. These changes disrupt mitochondrial structure, causing fragmentation and a loss of functional mitochondrial mass in {Delta}sod1. ALS-linked SOD1 mutants show similar effects: they diminish Sdh3 import by weakening SOD1-Tim23 interaction and lowering TIM23 complex stability, resulting in punctate mitochondria and reduced mitochondrial mass. Collectively, our study identifies the SOD1-TIM23 interaction as a key regulator of mitochondrial health through Sdh3 import via the TIM23CORE complex and indicates this pathway as a potential early intervention target for ALS therapy.